Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

Abstract The presence of extramedullary disease (EMD) has been associated with poor outcomes in patients with relapsed-refractory multiple myeloma (RRMM). Herein, we report the outcomes of RRMM patients who were treated with standard-of-care (SOC) chimeric antigen receptor (CAR) T-cell therapy and h...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Danai Dima, Al-Ola Abdallah, James A. Davis, Hussein Awada, Utkarsh Goel, Aliya Rashid, Shaun DeJarnette, Faiz Anwer, Leyla Shune, Shahzad Raza, Zahra Mahmoudjafari, Louis Williams, Beth Faiman, Joseph P. McGuirk, Craig S. Sauter, Nausheen Ahmed, Jack Khouri, Hamza Hashmi
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Publishing Group 2024-05-01
Reeks:	Blood Cancer Journal
Online toegang:	https://doi.org/10.1038/s41408-024-01068-w
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!